Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Charles Donnelly"'
Autor:
Bin Sun, Nilanjan Sengupta, Anita Rao, Charles Donnelly, Vinit Waichale, Arnab Sinha Roy, Shilpa Ramaswamy, Divya Pathak, Ronald R. Bowsher, Yaron Raiter, Patrick Aubonnet, Abhijit Barve
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background MYL-1501D is a proposed biosimilar to insulin glargine. The noninferiority of MYL-1501D was demonstrated in patients with type 1 diabetes and type 2 diabetes in 2 phase 3 trials. Immunogenicity of MYL-1501D and reference insulin g
Externí odkaz:
https://doaj.org/article/0bf18c5df35148c4bf95a40d112ace9c
Autor:
Mark A. Socinski, Cornelius F. Waller, Tazeen Idris, Igor Bondarenko, Alexander Luft, Katrin Beckmann, Ashwini Vishweswaramurthy, Subramanian Loganathan, Charles Donnelly, Matthew A. Hummel, Roxann Shapiro, Melody Woods, Anita Rao, Vivek G Nayak, Gopinath Ranganna, Abhijit Barve
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Purpose: This phase III study compared the efficacy and safety of proposed biosimilar MYL-1402O with reference bevacizumab (BEV), as first-line treatment for patients with stage IV non-squamous non-small-cell lung cancer. Patients and methods: Patien
Externí odkaz:
https://doaj.org/article/c16131d828264fbc8bb2cf1ee253522f
Publikováno v:
Transportation Research Record: Journal of the Transportation Research Board. 2675:280-292
Transverse joint faulting is a distress that develops in unbonded concrete overlays (UBOL). Historically, faulting models used for predicting the performance of a UBOL have not accounted for the effects of the interlayer between the overlay and the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cbaeca6833f231bf82003a0d5c849bd
https://doi.org/10.1177/03611981211028861
https://doi.org/10.1177/03611981211028861
Autor:
Ronald R Bowsher, Divya Pathak, Patrick Aubonnet, Charles Donnelly, Vinit S. Waichale, Bin Sun, Yaron Raiter, Abhijit Barve, Anita Rao, Shilpa G Ramaswamy, Nilanjan Sengupta, Arnab Sinha Roy
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Endocrine Disorders
BMC Endocrine Disorders
Background MYL-1501D is a proposed biosimilar to insulin glargine. The noninferiority of MYL-1501D was demonstrated in patients with type 1 diabetes and type 2 diabetes in 2 phase 3 trials. Immunogenicity of MYL-1501D and reference insulin glargine w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462494f86002b679d45e3482b3a5cb83
https://doaj.org/article/0bf18c5df35148c4bf95a40d112ace9c
https://doaj.org/article/0bf18c5df35148c4bf95a40d112ace9c
Autor:
Thomas C, Blevins, Yaron, Raiter, Bin, Sun, Charles, Donnelly, Roxann, Shapiro, Anoop, Chullikana, Anita, Rao, Laxmikant, Vashishta, Gopinath, Ranganna, Abhijit, Barve
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 36(6)
MYL-1601D is a proposed biosimilar of originator insulin aspart, NovologThis study assessed the immunogenicity, efficacy, and safety of MYL-1601D with Ref-InsAsp-US in patients with type 1 diabetes mellitus (T1D).This was a 24-week, open-label, rando
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc717101a2617d3a8de30f3eabb24e8a
https://pubmed.ncbi.nlm.nih.gov/36114990
https://pubmed.ncbi.nlm.nih.gov/36114990
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To report phase 1 bioequivalence results comparing MYL-1501D, US reference insulin glargine (US IG), and European reference insulin glargine (EU IG). Materials and methods The double-blind, randomized, three-way crossover study compared the phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99d95bf6261a04bfbc409640383734f7
https://doi.org/10.1111/dom.13919
https://doi.org/10.1111/dom.13919
Autor:
Charles Donnelly, Julie Vandenbossche
Publikováno v:
Proceedings of the 12th International Conference on Concrete Pavements.
Superloads are typically defined as vehicles weighing greater than 890 kilonewtons (200,000 pounds), although the geometrics of the vehicle are also a consideration. The damage of these superloads on jointed plain concrete pavements (JPCP) as compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a0884894400c1bed316d7f6440f08e8
https://doi.org/10.33593/kpufzjey
https://doi.org/10.33593/kpufzjey
Autor:
Ulrike, Hövelmann, Yaron, Raiter, Anoop, Chullikana, Mark, Liu, Charles, Donnelly, Tracey, Lawrence, Nilanjan, Sengupta, Gopu, Cl, Gopinath, Ranganna, Abhijit, Barve
Publikováno v:
Diabetes, obesitymetabolism. 23(12)
To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) bioequivalence (BE) of MYL-1601D biosimilar with originator, NovoLog (Ref-InsAsp-US), and NovoRapid (Ref-InsAsp-EU).This was a double-blind, randomized, crossover study that enrolled 71 he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccf59c2fe170fefc85f32dd839f9006b
https://pubmed.ncbi.nlm.nih.gov/34378861
https://pubmed.ncbi.nlm.nih.gov/34378861
Autor:
null Ulrike Hövelmann, null Yaron Raiter, null Anoop Chullikana, null Mark Liu, null Charles Donnelly, null Tracey Lawrence, null Nilanjan Sengupta, null Gopu CL, null Gopinath Ranganna, null Abhijit Barve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a0e45e048e51435d8b81b093cc3286
https://doi.org/10.1111/dom.14519/v2/response1
https://doi.org/10.1111/dom.14519/v2/response1
Autor:
Gopinath Ranganna, Yaron Raiter, Roxann Shapiro, Bin Sun, Thomas Blevins, Charles Donnelly, Laxmikant Vashishta, Anoop Chullikana, Anita U. Rao, Abhijit Barve
Publikováno v:
Diabetes. 70
MYL-1601D is a rapid-acting human insulin analog produced by recombinant DNA technology utilizing Pichia pastoris yeast. This was a randomized, multicenter, open-label, parallel-group study to compare the safety and efficacy of MYL-1601D with NovoLog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea5213752dbd1354ce7e21296ffd2aa
https://doi.org/10.2337/db21-741-p
https://doi.org/10.2337/db21-741-p